
Events Search and Views Navigation
June 2021
SaferWorldbyDesign Webinar: A novel in vitro approach for quantitative assessment of skin sensitizing potency
This presentation will introduce GARDskin Dose-Response assay, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. Results demonstrate that induction of toxicity pathways in GARDskin Dose-Response appears to be highly dose-dependent, and the lowest concentration required to induce a positive classification in the assay correlates strongly and significantly with both LLNA EC3 and human NOEL values. A case study will be used to illustrate how the experimentally derived values from the GARDskin Dose-response assay…
Find out more »September 2021
Webinar: How is GARD used for skin sensitization testing?
User cases on hazard and potency assessment Given the huge interest in our previous webinar on GARD user cases, we are pleased to offer you a new opportunity to hear how our customers use GARD to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. Key topics We will provide several user cases on how the GARD assays have been used for skin sensitization testing to demonstrate: Hazard assessment of “difficult-to-test” samples such as complex…
Find out more »October 2021
Webinar: Safer Medical Devices – In Vitro Assays As Part of a Biological Evaluation
In this webinar, the speakers will discuss the uses of in vitro assays as a part of the risk assessment and biological evaluation for the following endpoints: cytotoxicity, skin irritation and skin sensitization. Key topics The presentation will introduce biological evaluation and biocompatibility testing of medical devices, with focus on in vitro assays for skin irritation and skin sensitization now implemented in the ISO 10993-23:2021 and ISO/FDIS 10993-10:2021. For assessment of skin sensitization, the GARD™-technology will be introduced and the speakers will discuss how it can be used as…
Find out more »November 2021
Webinar: Recap on SenzaGen’s Eurotox Industry Symposium
Filling data gaps in skin sensitization testing: In vitro hazard and potency assessment using GARD In case you missed SenzaGen's industry symposium at this year's Eurotox Virtual Congress, here is a new opportunity! Together with guest speakers from Corteva Agriscience and Essity Hygiene & Health, we will present customer cases where the in vitro GARD assays have been successfully utilized to fill data gaps in skin sensitization hazard and potency testing. The webinar will last around 50 minutes, followed by a live…
Find out more »Webinar: Safety Testing of Cosmetic Products
An Overview of Established Methods and New Approach Methodologies (NAMs) In this joint webinar, we will present an overview of established methods and New Approach Methodologies (NAMs) used in the safety testing of cosmetic products. The webinar will start with a recorded presentation followed by a live Q&A session. If you cannot attend the live event, register now to get access to the recording. Key topics and speakers Register now
Find out more »December 2021
SaferWorldbyDesign Webinar: Skin safety assessment according to OECD guidelines
Join our skin sensitization expert Dr Andy Forreryd at this SaferWorldbyDesign webinar & panel discussion to learn more about skin safety assessment. Read more and register here
Find out more »January 2022
Webinar: Why Choose GARD™ for Skin Sensitization Testing?
High performance, broad applicability, quantitative potency Join us for this webinar to get the latest news about the in vitro GARD assays and how they are used to fill data gaps and address challenges in skin sensitization testing, such as “difficult-to-test” substances, quantitative potency assessment, testing of medical devices and solid materials. Key topics An introduction to GARD: How the genomic and machine learning-based technology works and its applications Case studies: "Difficult-to-test" samples such as complex mixtures, pre/pro- haptens and substances…
Find out more »February 2022
Webinar: Safer Medical Devices – In vitro assays as part of your biological evaluation
In this webinar, our Medical Device and ISO expert Dr Rose-Marie Jenvert will tell you more about how you can use in vitro methods for the biological evaluation of medical devices, now offered at our GLP certified laboratories. She will also introduce you to our expanded medical device offering and how we can help you to comply with MDR. The webinar will last around 45 minutes, followed by a live Q&A. Even If you cannot attend the live event, make…
Find out more »